Greentech spinout Seloxium takes lab and office space at ARC Oxford

Seloxium has joined the growing community of science and tech companies at ARC Oxford business park.

A spinout from the University of Oxford, the firm is looking to change the way valuable metals are mined, refined, processed and recycled.

Its new patented technology offers a more sustainable environmentally friendly source for some of the many green metals needed to meet global climate goals.

Dr Christian Peters, CEO Seloxium Ltd. Said: “We are delighted to be joining the community of cutting-edge scientific companies based at ARC.

Visit Hampshire Biz News for bright, upbeat and positive business news from the county

“The team at Seloxium looks forward to being part of the successful and thriving community of innovative companies making the world a greener and more sustainable place.”

Among those firms are Oxford Biomedica (manufacturers of the AstraZeneca Covid vaccine), MiroBio (antibody drugs for autoimmune disorders) and Ivy Farm (cultivated meat).

FluoRok also announced last December its plans to relocate to the Oxford campus of ARC, which is set to invest more than £1 billion in the county.

David Williams, Senior Director of Leasing at ARC, added: “We’re delighted to welcome Seloxium to our community of world-changing companies.

“We’re working closely with Seloxium during the fit-out process to ensure their overall space and laboratories are designed and built to help support the company to grow.”

Read more - Guildford’s Eagle Eye to deploy new AI platform for Canadian retail giant